Work

Conversion to Resection After Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Borderline Resectable CCA: A Real-World Exploratory Analysis

Year: 2025

Type: article

Study design: Observational Study

Source: Annals of Surgical Oncology

DOI: 10.1245/s10434-025-17991-6

Authors: Yawen Dong, Jonas Santol, Vanja Podrascanin, Zhihao Li, Markus Ammann, Lionel A. Kankeu Fonkoua, Rondell P. Graham, Caitlin B. Conboy, Nguyen H. Tran, Susanne G. Warner, Rory L. Smoot, Patrick P. Starlinger

Institutions: Sigmund Freud Privatuniversität Wien, Mayo Clinic, Universitätsklinikum Wiener Neustadt

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4412929771

FWCI: 2.797

Cites: 25

Cited by: 3

Related to: 10